Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Promega Introduces Maxwell 16 LEV RNA FFPE Kit
Tuesday, April 01, 2014
New kit provides high yield, pure and amplifiable RNA from FFPE mammalian tissue samples.

Identifying Epigenetic Biomarkers for Prostate Cancer
Tuesday, April 01, 2014
IDT qPCR assays and probes facilitate the development of predictive epigenetic biomarkers.

GenTegra LLC Launches New RNA Ambient Stabilization Product
Friday, March 28, 2014
Protect RNA samples immediately, and for all its tomorrows.

EKF Molecular Highlights Ultra-Sensitive Cancer Mutation Detection Kits
Wednesday, March 26, 2014
PointMan™ DNA-enrichment kits offer unrivalled cancer gene detection in whole blood.

JBS Publication Demonstrates Utility of InSphero 3D Co-Culture Microtissues as Phenotypic RNAi Screening Tool
Friday, March 21, 2014
Report in the Journal of Biomolecular Screening establishes fluorescent 3D tumor co-culture model, enables screening of gene function in a system more reflective of in vivo tumor growth.

Telstar Provides Safety Cabinets to NUI Galway’s Biomedical Research Facility
Wednesday, March 19, 2014
The new, recently inaugurated research facility, which is directed towards cancer research, regenerative medicine and glycosciences, takes its place as one of five global hubs in the medtech sector.

Advancing CRISPR Research with gBlocks Gene Fragments
Tuesday, March 18, 2014
Sequence and application flexibility allow for the exploration of CRISPR and Cas9 function.

IDT Reduces Undesirable Effects of RNAi Protocols
Wednesday, March 12, 2014
Learn about the latest advances at the Aptamers and RNAi conferences in Oxford, UK.

Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 651
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv